glp-1 and alcohol cravings Are Drugs the Future of Addiction Treatment? IUPHAR review – Glucagon-like peptide-1

Exogenous incretin therapy restores mealtime insulin responses and curbs glucagon secretion, directly targeting these defects

California joined New Hampshire, Pennsylvania and South Carolina in ending coverage for adult obesity treatment, while other states are planning or considering restrictions

Knowing alternatives and assistance programs can reduce out-of-pocket expenses

In 2019, getting a semaglutide prescription required an in-person visit with an endocrinologist, a documented history of failed weight loss attempts, and often months of waiting for an appointment

The new study of 27,000+ participants from 23andMe identified DNA variants that can impact weight loss and nausea while on GLP-1s